Researchers created a new kind of cancer drug that can grab a mutant protein while also carrying a second hit against the cell.

SAN ANTONIO, Texas — Researchers have made a major breakthrough that could transform IV medications into oral treatments for diseases like brain cancer and Alzheimer’s, potentially revolutionizing how ...

Hundreds of protein-ligand interactions have been identified through a collaboration between the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and Pfizer. Georg ...

Over decades, antibodies have established themselves as a key therapeutic modality for a wide range of diseases. But antibodies as they are found in nature did not evolve to be used as drugs, says ...

Explore how peptide drugs are changing the hundred-billion-level weight loss market, and how this landscape is changing as ...

Located at the cellular interface, membrane proteins play critical regulatory roles in the signaling between a cell and its interacting environment, making them popular and ideal drug targets.

Scientists mapped where drugs bind inside the body, cell by cell, to better understand benefits and side effects.

Designing drugs is a bit like playing with Polly Pocket. The vintage toy is a plastic clam shell that contains a multi-bedroom house, a skating rink, a disco dance floor, and other fun scenarios. Kids ...

At the heart of every biological process, from the replication of cells to the functioning of the human brain, lies the intricate world of proteins. Understanding the structure of these molecules, ...

Lariocidin hits drug-resistant bacteria where others fail — by hijacking the ribosome at a new site, bypassing defences, and opening the door to a new generation of antibiotics. Lariocidin, a ...